(Q53307646)

13 May 2018

title

Preadolescent non- and hyporesponders following three doses of hepatitis B vaccine need only one more dose. (English)

1 reference

13 May 2018

1 reference

3

Gaston De Serres

1 reference

13 May 2018

author name string

Bernard Duval

1

1 reference

13 May 2018

Nicole Boulianne

2

1 reference

13 May 2018

Philippe De Wals

4

1 reference

13 May 2018

Richard Massé

5

1 reference

13 May 2018

Gisèle Trudeau

6

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 November 2002

1 reference

13 May 2018

published in

Vaccine

1 reference

13 May 2018

volume

20

1 reference

13 May 2018

issue

31-32

1 reference

13 May 2018

page(s)

3632-3634

1 reference

13 May 2018

Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

Clinical experience with hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

Immune response to hepatitis B revaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

Immunisation of staff of a regional blood transfusion centre with a recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

High rate of seroconversion following administration of a single supplementary dose of recombinant hepatitis B vaccine in Iranian healthy nonresponder neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

Nonresponse to hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

Response to supplementary vaccination with recombinant or plasma hepatitis B vaccine in healthy non-responding children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900377-8

7 January 2021

10.1016/S0264-410X(02)00377-8

Identifiers

DOI

1 reference

13 May 2018

release_gvyjz5pfcvbcjoh4hlt3terbz4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gvyjz5pfcvbcjoh4hlt3terbz4

24 November 2022

mapped directly with Wikidata item

1 reference

13 May 2018